Alere Completes Epocal Purchase

On Wednesday, home health facilitator Alere (NYSE: ALR  ) announced that it has completed its purchase of blood gas and electrolyte tester Epocal, a deal first announced in 2009, but one that was made contingent upon Epocal hitting certain gross margin and other financial targets prior to October 31, 2014.

Epocal has since hit these targets, triggering Alere's obligation to purchase for $166 million in cash. Alere may be required to pay up to $75.5 million in additional payments in the future based on a clause linking additional payments to "the delivery of additional product offerings on the Epocal platform."

Alere shares closed down slightly yesterday in response to the news, but are on the rise today, up 1%, at $22.02.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2243588, ~/Articles/ArticleHandler.aspx, 4/24/2014 7:36:53 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 10 hours ago Sponsored by:
DOW 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASD 4,126.97 0.00 0.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

4/23/2014 4:02 PM
ALR $36.27 Down -0.13 -0.36%
Alere Inc. CAPS Rating: ***